H.R. 7868 · 119th Congress · Health

Expanding Support for Living Donors Act of 2026

In committee1.2k words Introduced Mar 9, 2026 · Latest action Mar 9, 2026

How far it has goneStage 2 of 6
  1. IntroducedMar 9, 2026 Done
  2. CommitteeReferred to 2 committees Current stage
  3. House floorNot yet Not reached yet
  4. Senate floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

What it does

The Congressional Research Service hasn’t published a summary of this bill. Read the full text on Congress.gov.

Who lobbies on it

1 organization · 3 filings · Q1 2026–Q3 2026

See which of this bill’s sponsors and cosponsors got money from American Medical Association’s PAC → Pro

One square per quarter since introduction, oldest left. Filled = named it that quarter.

  1. American Medical Association 3 of 3 quarters
    “…H.R.7868 - Expanding Support for Living Donors Act of 2026, all provisions H.R.7884 - Healthcare is Human Act of 2026, all provisions H.R.8794 - FED UP with Bleeding Disorders Act of 2026, all provisions H.R.9192 - Prior Authorization Reform for Autoimmune and Blood Disorders Act, all provisions H.R.929 - Dr. Lorna…”

    $17.6M lobbying spend in 2026 to date, all issuesQ3 2026 filing

Organizations that named H.R. 7868 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.

Actions

2 actions · newest first
  1. Mar 9, 2026Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  2. Mar 9, 2026Introduced in House